|
Aug 16
|
Fortress Biotech Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 14
|
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 14
|
Fortress Biotech: Q2 Earnings Snapshot
|
|
Aug 14
|
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
|
|
Aug 12
|
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
|
|
Aug 7
|
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
|
|
Aug 5
|
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
|
|
Jun 24
|
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
|
|
Jun 20
|
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
|
|
Jun 19
|
Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock
|
|
May 17
|
Fortress Biotech First Quarter 2025 Earnings: Beats Expectations
|
|
Apr 9
|
This Fortress Biotech Insider Increased Their Holding By 26% Last Year
|
|
Mar 14
|
Biotech Alert: Searches spiking for these stocks today
|
|
Mar 12
|
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
|
|
Mar 10
|
Update: Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -- Checkpoint Shares Jump Monday
|
|
Mar 10
|
Sun Pharma to Acquire Checkpoint Therapeutics
|
|
Feb 11
|
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
|
Feb 10
|
Mustang Bio Announces Closing of $8 Million Public Offering
|
|
Feb 6
|
Mustang Bio Announces Pricing of $8 Million Public Offering
|